Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
SEC Filing Details Document Details Form 8-K Filing Date Nov 6, 2024 Document Date Nov 6, 2024 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filing Formats View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.DEF - XBRL DEFINITION FILE EX-101.LAB - XBRL LABEL FILE EX-101.PRE - XBRL PRESENTATION FILE XML - XBRL INSTANCE DOCUMENT Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
SEC Filing Details Document Details Form 8-K Filing Date Nov 6, 2024 Document Date Nov 6, 2024 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filing Formats View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.DEF - XBRL DEFINITION FILE EX-101.LAB - XBRL LABEL FILE EX-101.PRE - XBRL PRESENTATION FILE XML - XBRL INSTANCE DOCUMENT Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library